# The Influence of Polymorphisms of Interleukin-17A and Interleukin-17F Genes on the Susceptibility to Ulcerative Colitis

- **DOI:** [10.1007/s10875-007-9125-8](https://doi.org/10.1007/s10875-007-9125-8)
- **Rating:** Limited (2.9 out of 5)
- **Verdict:** A novel candidate-gene study links IL-17 variants to ulcerative colitis, but uncorrected subgroup testing confines the findings to hypothesis generation.
- **Framework version:** v5.8
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-08-19
- **Evaluation page:** https://www.nabu.science/paper/10.1007%2Fs10875-007-9125-8

## Key claims

1. Both the numbers of -197A (IL-17A) and 7488T (IL-17F) alleles were significantly correlated to the development of UC.
   - Support: Tentative
   - Type: Primary finding
   - Basis: single-cohort case-control evidence with an inconsistent IL-17A frequency and no independent replication
   - Location: Abstract
2. An adjusted analysis revealed that -197A and 7488T alleles were independent risk factors for the developing UC.
   - Support: Tentative
   - Type: Secondary
   - Basis: retrospective association design supports adjusted correlation but not robust independent-risk attribution
   - Location: Abstract; Results, Table II
3. Both polymorphisms were significantly associated with the pancolitis phenotype.
   - Support: Tentative
   - Type: Secondary
   - Basis: small phenotype subgroup tested among numerous comparisons without multiplicity correction
   - Location: Abstract; Results, Tables III–IV
4. -197A allele was significantly correlated to the chronic relapsing phenotype and -197A/A homozygote was more frequent in steroid-dependent cases, whereas 7488T allele was correlated with the chronic continuous phenotype.
   - Support: Tentative
   - Type: Secondary
   - Basis: multiple small subgroup analyses without correction produce fragile phenotype-specific evidence
   - Location: Abstract; Results, Tables III–IV

## Strengths

- **Novel IL-17 genetic association tested** The study directly examines two IL-17 polymorphisms in 111 ulcerative colitis cases and 248 controls, addressing a clearly stated candidate-gene question.
  - Dimension: contribution
  - Location: Introduction; Materials and Methods, Clinical Samples
- **Adjusted susceptibility models supplement comparisons** Table II reports logistic regression adjusted for age, gender, and both polymorphisms, adding inferential support beyond the unadjusted allele and genotype comparisons.
  - Dimension: methodological rigour
  - Location: Statistical Analysis; Results, Table II
- **Relevant functional literature is engaged** The Discussion relates the IL-17F variant to functional asthma evidence and addresses a conflicting asthma study through population allele-frequency differences.
  - Dimension: positioning
  - Location: Discussion, paragraphs citing Kawaguchi et al. and Ramsey et al.

## Limitations

- **Uncorrected tests use small subgroups** Tables III–IV test numerous clinical strata, including groups as small as nine or 22 participants, without a multiple-testing correction. Several reported intervals approach or cross the null.
  - Dimension: methodological rigour
  - Location: Results, Tables III–IV
- **IL-17A frequency is internally inconsistent** The 40.3% control A-allele frequency in Table I does not match the displayed genotype counts, which imply approximately 33.9%. This also makes the accompanying statement of no allele-frequency difference uncertain.
  - Dimension: reporting
  - Location: Results, Table I
- **Key limitations remain uncontextualised** The Discussion does not address the case-control age imbalance, subgroup multiplicity, or absent genotyping reproducibility measures, despite their bearing on certainty and scope.
  - Dimension: positioning
  - Location: Results, Table I and Tables III–IV; Discussion

## Reliability checks

Caveats (4 of 4 checks).

- **Internal coherence:** Noted. Reported IL-17A control allele frequency is inconsistent with the genotype counts, and the phenotype analyses contain numerous small, uncorrected comparisons. These issues create uncertainty without rendering the adjusted susceptibility analysis uninterpretable.
- **Research conduct:** Clean. Ethics approval and written informed consent are declared. The absence of conflict-of-interest, data, code, and preregistration statements is treated as era-typical reporting rather than a conduct concern.
- **Reference integrity:** Clean. 31 of 31 checkable references verified
  - 32 references in manuscript
  - 1 have no canonical index record — counted, but not index-checkable
  - 1 reference confirmed by manual review
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
